Found 9693 bookmarks
Newest
Offline Two-Dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation - PubMed
Offline Two-Dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation - PubMed
Biological interpretation of untargeted LC-MS-based metabolomics data depends on accurate compound identification, but current techniques fall short of identifying most features that can be detected. The human fecal metabolome is complex, variable, incompletely annotated, and serves as an ideal matr …
·pubmed.ncbi.nlm.nih.gov·
Offline Two-Dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation - PubMed
Can fecal microbiota transplantations modulate autoimmune responses in type 1 diabetes? - PubMed
Can fecal microbiota transplantations modulate autoimmune responses in type 1 diabetes? - PubMed
Type 1 diabetes (T1D) is a chronic autoimmune disease targeting insulin-producing pancreatic beta cells. T1D is a multifactorial disease incorporating genetic and environmental factors. In recent years, the advances in high-throughput sequencing have allowed researchers to elucidate the changes in t …
·pubmed.ncbi.nlm.nih.gov·
Can fecal microbiota transplantations modulate autoimmune responses in type 1 diabetes? - PubMed
Offline Two-Dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation - PubMed
Offline Two-Dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation - PubMed
Biological interpretation of untargeted LC-MS-based metabolomics data depends on accurate compound identification, but current techniques fall short of identifying most features that can be detected. The human fecal metabolome is complex, variable, incompletely annotated, and serves as an ideal matr …
·pubmed.ncbi.nlm.nih.gov·
Offline Two-Dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation - PubMed
Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile - PubMed
Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile - PubMed
The pilW_4-plex PCR assay is an accurate and rapid method with high sensitivity and specificity for identification of ST1 and detection of toxigenic C. difficile in stool.
·pubmed.ncbi.nlm.nih.gov·
Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile - PubMed
Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile - PubMed
Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile - PubMed
The pilW_4-plex PCR assay is an accurate and rapid method with high sensitivity and specificity for identification of ST1 and detection of toxigenic C. difficile in stool.
·pubmed.ncbi.nlm.nih.gov·
Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile - PubMed
Successful allogeneic fecal microbiota transplantation for severe diversion colitis: a case report - PubMed
Successful allogeneic fecal microbiota transplantation for severe diversion colitis: a case report - PubMed
Ileostomy diverts the flow of feces, which can result in malnutrition in the distal part of the intestine. The diversity of the gut microbiota consequently decreases, ultimately leading to intestinal dysbiosis and dysfunction. This condition can readily result in diversion colitis (DC). Potential tr …
·pubmed.ncbi.nlm.nih.gov·
Successful allogeneic fecal microbiota transplantation for severe diversion colitis: a case report - PubMed
Stachyose Exerts Anticolitis Efficacy by Re-balancing Treg/Th17 and Activating the Butyrate-Derived PPARγ Signaling Pathway - PubMed
Stachyose Exerts Anticolitis Efficacy by Re-balancing Treg/Th17 and Activating the Butyrate-Derived PPARγ Signaling Pathway - PubMed
Ulcerative colitis (UC) is a complex chronic inflammatory disease closely associated with gut homeostasis dysfunction. The previous studies have shown that stachyose, a functional food additive, has the potential to enhance gut health and alleviate UC symptoms. However, the underlying mechanism of i …
·pubmed.ncbi.nlm.nih.gov·
Stachyose Exerts Anticolitis Efficacy by Re-balancing Treg/Th17 and Activating the Butyrate-Derived PPARγ Signaling Pathway - PubMed
Microbiota transplantation in restoring cesarean-related infant dysbiosis: a new frontier - PubMed
Microbiota transplantation in restoring cesarean-related infant dysbiosis: a new frontier - PubMed
C-section is crucial in reducing maternal and neonatal mortality when medically indicated, but one of its side effects could be the disruption of vertical transmission of maternal-infant microbiota during delivery, potentially leading to gut dysbiosis and increased disease risks in C-section infants …
·pubmed.ncbi.nlm.nih.gov·
Microbiota transplantation in restoring cesarean-related infant dysbiosis: a new frontier - PubMed
The surprising origin of a deadly hospital infection
The surprising origin of a deadly hospital infection
Surprising findings from a Michigan Medicine study in Nature Medicine suggest that the burden of C. diff infection may be less a matter of hospital transmission and more a result of characteristics associated with the patients themselves.
·news.google.com·
The surprising origin of a deadly hospital infection
Secondary prophylaxis for Clostridioides difficile infection for patients on non-C. difficile antibiotics: a retrospective cohort study - PubMed
Secondary prophylaxis for Clostridioides difficile infection for patients on non-C. difficile antibiotics: a retrospective cohort study - PubMed
Secondary prophylaxis with CDI antibiotics appears to be associated with a reduced risk of recurrence in patients with previous non-severe CDI episode. Further studies are needed to confirm this finding.
·pubmed.ncbi.nlm.nih.gov·
Secondary prophylaxis for Clostridioides difficile infection for patients on non-C. difficile antibiotics: a retrospective cohort study - PubMed
Fecal transplant from vaginally seeded infants decreases intraabdominal adiposity in mice - PubMed
Fecal transplant from vaginally seeded infants decreases intraabdominal adiposity in mice - PubMed
Exposing C-section infants to the maternal vaginal microbiome, coined "vaginal seeding", partially restores microbial colonization. However, whether vaginal seeding decreases metabolic disease risk is unknown. Therefore, we assessed the effect of vaginal seeding of human infants on adiposity in a mu …
·pubmed.ncbi.nlm.nih.gov·
Fecal transplant from vaginally seeded infants decreases intraabdominal adiposity in mice - PubMed
Microbiota and arthritis: cause or consequence? - PubMed
Microbiota and arthritis: cause or consequence? - PubMed
The relationship between intestinal microbiota and arthritis has garnered significant attention, with emerging evidence suggesting a potential association between dysbiosis and various forms of inflammatory arthropathies. While observational studies have provided valuable insights into microbiota al …
·pubmed.ncbi.nlm.nih.gov·
Microbiota and arthritis: cause or consequence? - PubMed
KipOTIA detoxifies 5-oxoproline and promotes the growth of Clostridioides difficile - PubMed
KipOTIA detoxifies 5-oxoproline and promotes the growth of Clostridioides difficile - PubMed
Clostridioides difficile is an anaerobic enteric pathogen that disseminates in the environment as a dormant spore. For C. difficile and other sporulating bacteria, the initiation of sporulation is a regulated process that prevents spore formation under favorable growth conditions. In …
·pubmed.ncbi.nlm.nih.gov·
KipOTIA detoxifies 5-oxoproline and promotes the growth of Clostridioides difficile - PubMed
Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection - PubMed
Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection - PubMed
Clostridioides difficile infection (CDI) is one of the leading causes of healthcare- and antibiotic-associated diarrhea. While fecal microbiota transplantation (FMT) has emerged as a promising therapy for recurrent CDI, its exact mechanisms of action and long-term safety are not fully underst …
·pubmed.ncbi.nlm.nih.gov·
Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection - PubMed
Living With C diff: Witnessing and Participating in an Evolution of Awareness, Medical Care
Living With C diff: Witnessing and Participating in an Evolution of Awareness, Medical Care
Dennis Petragnani has battled gastrointestinal issues for years, and he shares what he sees as the transformation of change in the public and medical community talking about C diff and therapies around it, and the kinship with people he has met through the Peggy Lillis Foundation.
·news.google.com·
Living With C diff: Witnessing and Participating in an Evolution of Awareness, Medical Care
Fecal Microbiota Transplantation Attenuates Frailty via Gut-Muscle Axis in Old Mice - PubMed
Fecal Microbiota Transplantation Attenuates Frailty via Gut-Muscle Axis in Old Mice - PubMed
Targeting adverse pathogenic gut microbiota regulation through fecal microbiota transplantation (FMT) may restore health and has been validated in some aging-related diseases. However, the mechanisms of the gut microbiota's role in frailty and whether modulation of the gut microbiota can treat age-r …
·pubmed.ncbi.nlm.nih.gov·
Fecal Microbiota Transplantation Attenuates Frailty via Gut-Muscle Axis in Old Mice - PubMed
Breaking the Cycle of Recurrent Clostridioides difficile Infections: A Narrative Review Exploring Current and Novel Therapeutic Strategies - PubMed
Breaking the Cycle of Recurrent Clostridioides difficile Infections: A Narrative Review Exploring Current and Novel Therapeutic Strategies - PubMed
Clostridioides difficile is a toxin-producing bacteria that is a main cause of antibiotic-associated diarrhea. Clostridioides difficile infections (CDI) are associated with disruptions within the gastrointestinal (GI) microbiota which can be further exacerbated by CDI-targeted antibiot …
·pubmed.ncbi.nlm.nih.gov·
Breaking the Cycle of Recurrent Clostridioides difficile Infections: A Narrative Review Exploring Current and Novel Therapeutic Strategies - PubMed
A conserved switch controls virulence, sporulation, and motility in C. difficile - PubMed
A conserved switch controls virulence, sporulation, and motility in C. difficile - PubMed
Spore formation is required for environmental survival and transmission of the human enteropathogenic Clostridioides difficile. In all bacterial spore formers, sporulation is regulated through activation of the master response regulator, Spo0A. However, the factors and mechanisms that directly regul …
·pubmed.ncbi.nlm.nih.gov·
A conserved switch controls virulence, sporulation, and motility in C. difficile - PubMed
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Pune, Feb. 19, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Clostridium Difficile Infections Treatment Market is expected to clock US$ 1,727.1 million by 2031 and to grow at a CAGR of 6.8% during the forecast period. The global Clostridium difficile Infections (CDI) Treatment Market is witnessing significant growth, driven by the rising incidence of CDI, increasing antibiotic resistance, and the demand for effective treatment options to com
·news.google.com·
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review - PubMed
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review - PubMed
The abundance and proportion of intestinal microorganisms influence the susceptibility of tumors to tumor immunotherapy. This article reviewed the effects and mechanisms of gut microbes on tumor immunotherapy to further explore the medical value of gut microbes in tumor immunotherapy.
·pubmed.ncbi.nlm.nih.gov·
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review - PubMed
The dual role of 20(S)-protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis - PubMed
The dual role of 20(S)-protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis - PubMed
This study positions PPD as a vanguard in the therapeutic landscape for pulmonary fibrosis, offering a dual mechanism of action that encompasses both modulation of gut microbiota and direct intervention at molecular targets. These insights highlight the immense therapeutic potential of harnessing th …
·pubmed.ncbi.nlm.nih.gov·
The dual role of 20(S)-protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis - PubMed
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway - PubMed
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway - PubMed
Gut microbiota variances reflecting the severity type 2 diabetes mellitus (T2DM). Achyranthes bidentata polysaccharide (ABP) can regulate gut microbiota. However, the hypoglycemic effect and underlying mechanism of ABP remain unclear. Herein, we characterized the structure of ABP and revealed the hy …
·pubmed.ncbi.nlm.nih.gov·
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway - PubMed
The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders - PubMed
The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders - PubMed
The role of the intestinal microbiota in the diagnosis and treatment of pancreatic diseases is increasingly significant. Consequently, fecal microbiota transplantation (FMT) is emerging as a promising therapeutic avenue for various pancreatic disorders, including cancer, pancreatitis, and type 1 dia …
·pubmed.ncbi.nlm.nih.gov·
The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders - PubMed
Sea Buckthorn Polysaccharide Ameliorates Colitis - PubMed
Sea Buckthorn Polysaccharide Ameliorates Colitis - PubMed
Ulcerative colitis (UC) is characterized by chronic inflammation and ulceration of the intestinal inner lining, resulting in various symptoms. Sea buckthorn berries contain a bioactive compound known as sea buckthorn polysaccharide (SBP). However, the precise mechanisms underlying the impact of SBP …
·pubmed.ncbi.nlm.nih.gov·
Sea Buckthorn Polysaccharide Ameliorates Colitis - PubMed
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis - PubMed
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis - PubMed
This study demonstrated that A. putredinis, a representative Bacteroidota species, exhibits anti-inflammatory effects in vivo and in vitro; however, the effects of other Bacteroidota species remain unexplored. Our fecal microbiota transplantation-based reverse translation approach using promising ba …
·pubmed.ncbi.nlm.nih.gov·
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis - PubMed